amiloride hydrochloride
NDC 0574-0292, amiloride hydrochloride, tablet, from Padagis US LLC.
- Product NDC
- 0574-0292
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA018200
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMILORIDE HYDROCHLORIDE5 mg/1
Pharmacologic classes
Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-0292-01 | 00574029201 | 100 TABLET in 1 BOTTLE (0574-0292-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2b70cf0c-45be-428f-b396-5001ed4e30fcNADAC price for package 00574029201
GET /v1/drugs/nadac/00574029201
Use it
Look up 0574-0292 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-0292. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.